18 0 2 0 2 O
years 3 8 3 8 O
of 9 11 9 11 O
age 12 15 12 15 B-age

De 0 2 16 18 B-cancer
novo 3 7 19 23 I-cancer
diffuse 8 15 24 31 I-cancer
large 16 21 32 37 I-cancer
B 22 23 38 39 I-cancer
- 23 24 39 40 I-cancer
cell 24 28 40 44 I-cancer
lymphoma 29 37 45 53 I-cancer
( 38 39 54 55 O
including 39 48 55 64 O
all 49 52 65 68 O
subtypes 53 61 69 77 O
such 62 66 78 82 O
as 67 69 83 85 O
primary 70 77 86 93 B-cancer
mediastinal 78 89 94 105 I-cancer
B 90 91 106 107 I-cancer
- 91 92 107 108 I-cancer
cell 92 96 108 112 I-cancer
lymphoma 97 105 113 121 I-cancer
and 106 109 122 125 O
T 110 111 126 127 B-cancer
- 111 112 127 128 I-cancer
cell 112 116 128 132 I-cancer
rich 117 121 133 137 I-cancer
B 122 123 138 139 I-cancer
- 123 124 139 140 I-cancer
cell 124 128 140 144 I-cancer
lymphoma 129 137 145 153 I-cancer
) 137 138 153 154 O

Histology 0 9 155 164 O
- 9 10 164 165 O
confirmed 10 19 165 174 O
aggressive 20 30 175 185 O
B 31 32 186 187 B-cancer
- 32 33 187 188 I-cancer
cell 33 37 188 192 I-cancer
Non 38 41 193 196 I-cancer
- 41 42 196 197 I-cancer
Hodgkin 42 49 197 204 I-cancer
lymphoma 50 58 205 213 I-cancer

Patients 0 8 214 222 O
receiving 9 18 223 232 O
2nd 19 22 233 236 B-lower_bound
or 23 25 237 239 O
greater 26 33 240 247 O
line 34 38 248 252 O
of 39 41 253 255 O
therapy 42 49 256 263 B-treatment

Recipient 0 9 264 273 O
of 10 12 274 276 O
frontline 13 22 277 286 O
multi 23 28 287 292 B-treatment
- 28 29 292 293 I-treatment
agent 29 34 293 298 I-treatment
chemotherapy 35 47 299 311 I-treatment
( 48 49 312 313 O
for 49 52 313 316 O
example 53 60 317 324 O
, 60 61 324 325 O
RCHOP 62 67 326 331 B-treatment
, 67 68 331 332 O
dose 69 73 333 337 O
adjusted 74 82 338 346 O
- 82 83 346 347 O
REPOCH 83 89 347 353 B-treatment
, 89 90 353 354 O
RCHOP 91 96 355 360 B-treatment
/ 96 97 360 361 I-treatment
RICE 97 101 361 365 I-treatment
, 101 102 365 366 O
RCHOP+investigational 103 124 367 388 O
agent 125 130 389 394 O
, 130 131 394 395 O
etc 132 135 396 399 O
) 135 136 399 400 O

